108 related articles for article (PubMed ID: 33074590)
1. Efficacy and safety of linagliptin as add-on therapy to insulin in Chinese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial.
Yang W; Xu X; Lei T; Ma J; Li L; Shen J; Ye B; Zhu S; Meinicke T
Diabetes Obes Metab; 2021 Feb; 23(2):642-647. PubMed ID: 33074590
[TBL] [Abstract][Full Text] [Related]
2. Linagliptin, when compared to placebo, improves CD34+ve endothelial progenitor cells in type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin: a randomized controlled trial.
Awal HB; Nandula SR; Domingues CC; Dore FJ; Kundu N; Brichacek B; Fakhri M; Elzarki A; Ahmadi N; Safai S; Fosso M; Amdur RL; Sen S
Cardiovasc Diabetol; 2020 Jun; 19(1):72. PubMed ID: 32493344
[TBL] [Abstract][Full Text] [Related]
3. A Randomized, Double-Blind, Parallel-Group Phase III Trial Investigating the Glycemic Efficacy and Safety Profile of Fixed-Dose Combination Dapagliflozin and Linagliptin Over Linagliptin Monotherapy in Patients with Inadequately Controlled Type 2 Diabetes with Metformin.
Jain A; Vispute A; Dange A; Naskar A; Mondal A; Vivekanand B; Sharma B; Varade D; Shukla D; Bhatia G; Chaudhari H; Ram Babu K; Gavali O; Sorate S; Bhanushali S; Kothari V; Khandelwal V; Sharma A; Pawar R; Mayabhate M; Shahavi V; Rajput A; Jaiswal M
Diabetes Ther; 2024 Jan; 15(1):215-227. PubMed ID: 37957465
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the Efficacy, Safety, and Tolerability of Combination Therapy of Dapagliflozin and Linagliptin Over Dapagliflozin and Vildagliptin in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.
Dharmalingam M; Kumar Sharma S; Prakash V; Maiti A; Kumar R; Murthy LSS; Ramanathan B; Maheshwari S; Naik Kethavath S; Ogale D; Bachubhai PVK; Sonawane AB; Shah V; Suresh M; Chakraborty S; Kumar Manjunath K
Cureus; 2024 Apr; 16(4):e58115. PubMed ID: 38738005
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of linagliptin in type 2 diabetes subjects at high risk for renal and cardiovascular disease: a pooled analysis of six phase III clinical trials.
von Eynatten M; Gong Y; Emser A; Woerle HJ
Cardiovasc Diabetol; 2013 Apr; 12():60. PubMed ID: 23570327
[TBL] [Abstract][Full Text] [Related]
6. Dorzagliatin for Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Phase II/III Trials.
Lin F; He R; Ling B; Wang L; Jiang T; Yu B
Clin Ther; 2023 Dec; 45(12):1277-1283. PubMed ID: 37777375
[TBL] [Abstract][Full Text] [Related]
7. Linagliptin in combination with insulin suppresses apoptotic unfolded protein response in ovaries exposed to type 1 diabetes.
Okan A; Demir N; Doğanyiğit Z
Cell Biochem Funct; 2024 Mar; 42(2):e3898. PubMed ID: 38088568
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of linagliptin (tradjenta) in adults with type-2 diabetes mellitus.
Freeman MK
P T; 2011 Dec; 36(12):807-42. PubMed ID: 22346314
[No Abstract] [Full Text] [Related]
9. Empagliflozin treatment effects across categories of baseline HbA1c, body weight and blood pressure as an add-on to metformin in patients with type 2 diabetes.
Inzucchi SE; Davies MJ; Khunti K; Trivedi P; George JT; Zwiener I; Johansen OE; Sattar N
Diabetes Obes Metab; 2021 Feb; 23(2):425-433. PubMed ID: 33084149
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Visceral Fat Reduction by Ipragliflozin and Metformin in Elderly Type 2 Diabetes Patients: Sub-Analysis of a Randomized-Controlled Study.
Koshizaka M; Ishikawa K; Ishibashi R; Takahashi S; Sakamoto K; Yokoh H; Baba Y; Ide S; Ide K; Ishikawa T; Onishi S; Kobayashi K; Takemoto M; Horikoshi T; Shimofusa R; Maezawa Y; Yokote K
Diabetes Ther; 2021 Jan; 12(1):183-196. PubMed ID: 33098565
[TBL] [Abstract][Full Text] [Related]
11. Antidiabetic Drugs in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review.
Muñoz-Jiménez M; Zaarkti A; García-Arnés JA; García-Casares N
Dement Geriatr Cogn Disord; 2020; 49(5):423-434. PubMed ID: 33080602
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Multi-Vitamin/Multi-Mineral Supplementation on Nutritional Status in Older Adults Receiving Drug Therapies: A Double-Blind, Placebo-Controlled Trial.
Chen O; Rogers GT; McKay DL; Maki KC; Blumberg JB
J Diet Suppl; 2022; 19(1):20-33. PubMed ID: 33078646
[TBL] [Abstract][Full Text] [Related]
13. Effects of empagliflozin on proinflammatory cytokines and other coronary risk factors in patients with type 2 diabetes mellitus: A single-arm real-world observation.
Singh RB; Fatima G; Kumar P; Fedacko J; Mojto V; Isaza A; SinghVerma N; Maheshwari A; Joshi S; Saboo B; Saxena M
Int J Clin Pharmacol Ther; 2021 Jan; 59(1):17-25. PubMed ID: 33094728
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of
Zarei R; Nikpour P; Rashidi B; Eskandari N; Aboutorabi R
Int J Fertil Steril; 2020 Oct; 14(3):218-222. PubMed ID: 33098389
[TBL] [Abstract][Full Text] [Related]
15. New prescription of antihyperglycemic agents among patients with diabetes in Germany: Moderate concordance between health insurance data and self-reports.
Brüne M; Andrich S; Haastert B; Kaltheuner M; Icks A
Pharmacoepidemiol Drug Saf; 2021 Mar; 30(3):304-312. PubMed ID: 33098336
[TBL] [Abstract][Full Text] [Related]
16. Mechanochemical Synthesis and Structure of the Tetrahydrate and Mesoporous Anhydrous Metforminium(2+)-
Chong-Canto S; García-Báez EV; Martínez-Martínez FJ; Ramos-Organillo AA; Padilla-Martínez II
Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33096739
[TBL] [Abstract][Full Text] [Related]
17. Novel Sulfonamide-Based Analogs of Metformin Exert Promising Anti-Coagulant Effects without Compromising Glucose-Lowering Activity.
Markowicz-Piasecka M; Sadkowska A; Sikora J; Broncel M; Huttunen KM
Pharmaceuticals (Basel); 2020 Oct; 13(10):. PubMed ID: 33096688
[TBL] [Abstract][Full Text] [Related]
18. Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy.
Ashrafizadeh M; Zarrabi A; Hushmandi K; Hashemi F; Rahmani Moghadam E; Raei M; Kalantari M; Tavakol S; Mohammadinejad R; Najafi M; Tay FR; Makvandi P
ACS Comb Sci; 2020 Dec; 22(12):669-700. PubMed ID: 33095554
[TBL] [Abstract][Full Text] [Related]
19. Coadministration of metformin prevents olanzapine-induced metabolic dysfunction and regulates the gut-liver axis in rats.
Luo C; Wang X; Huang HX; Mao XY; Zhou HH; Liu ZQ
Psychopharmacology (Berl); 2021 Jan; 238(1):239-248. PubMed ID: 33095288
[TBL] [Abstract][Full Text] [Related]
20. Recycling the Purpose of Old Drugs to Treat Ovarian Cancer.
Nunes M; Henriques Abreu M; Bartosch C; Ricardo S
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
